Century Therapeutics

CompanyUnited StatesFounded 2018

Wikidata

Century Therapeutics develops one asset, preclinical (CNTY-813 in type 1 diabetes). Mostly cell therapy; based in the United States, founded in 2018.

1
Asset
Furthest stage
Preclinical
0
Trials
0
Signals

Pipeline

1
  • CNTY-813

    iPSC-derived islet replacement therapy for type 1 diabetes

    Preclinical, Cell therapy, type 1 diabetes

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies6

Intelligence